Board of Trustees of the University of Arkansas v. Secretary of Health & Human Services Case Brief

District Court, E.D. Arkansas2005Docket #2290480
354 F. Supp. 2d 924 2005 U.S. Dist. LEXIS 13465 2005 WL 245917 Administrative Law Health Law Civil Procedure

Complete case briefs with LSD+

Every LSD.Law brief pairs a full IRAC analysis with opinion summaries at three levels of depth, written by a team of Harvard Law and MIT graduates - a quick synopsis when you are pressed for time, the complete reasoning when you need to go deep.

Adaptive Case Views

Toggle between Flash, Standard, and Expanded. Get what you need, when you need it.

Exam-Ready IRAC Format

We deliver the precise structure professors look for in exam answers.

Complex Cases, Clarified

We break down dense legal reasoning into something digestible, helping you grasp core concepts.

Case Brief Summary & Legal Analysis

4 min read

tl;dr: A hospital challenged a Medicare denial for a cancer treatment package. The court reversed the agency, finding its denial of coverage for medically necessary high-dose chemotherapy, which was bundled with a non-covered stem cell transplant, was arbitrary and unsupported by substantial evidence.

Legal Significance: Demonstrates judicial review of agency action, holding that an agency cannot deny coverage for a medically necessary, covered service simply because it is administered in conjunction with a non-covered procedure, especially when the two are severable for billing and medical purposes.

Board of Trustees of the University of Arkansas v. Secretary of Health & Human Services Law School Study Guide

Use this case brief structure for your own legal analysis. Focus on the IRAC methodology to excel in law school exams and cold calls.

Case Facts & Court Holding

Key Facts & Case Background

The University of Arkansas Medical Center (UAMS) provided treatment for multiple myeloma to 12 Medicare patients. The treatment involved high-dose chemotherapy (HDC), a generally covered service, followed by an autologous stem cell transplant (ASCT) to mitigate the HDC’s toxic effects. At the time of treatment in 1999, a national coverage determination (NCD) under the Medicare Coverage Issues Manual (§ 35-30.1) explicitly excluded ASCT for multiple myeloma as not “reasonable and necessary.” The NCD did not mention HDC. The Medicare intermediary, acting for the Secretary of Health and Human Services, denied reimbursement for the entire hospital admission, bundling the covered HDC with the non-covered ASCT. An Administrative Law Judge (ALJ) upheld the denial, finding the “main purpose” of the admission was the non-covered transplant and that the HDC was “related to” it. UAMS appealed to the district court, arguing the denial was an incorrect application of the agency’s own regulations and that the services were severable. Uncontradicted medical testimony established that HDC was the primary cancer treatment and the reason for hospitalization, while the ASCT was a supportive, non-hospitalization-requiring procedure.

Court Holding & Legal Precedent

Issue: Did the Secretary of Health and Human Services act arbitrarily and capriciously or without substantial evidence by interpreting its regulations to deny Medicare coverage for medically necessary high-dose chemotherapy because it was administered in conjunction with a non-covered autologous stem cell transplant?

Yes. The court reversed the agency’s decision to deny coverage for the Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco la

Read the full analysis

The complete holding, rule, and analysis for this case are available to LSD+ subscribers.

Start 14-Day Free Trial

IRAC Legal Analysis

Premium Feature Unlock

About IRAC analysis

IRAC (Issue, Rule, Analysis, Conclusion) is the structure professors expect in exam answers. Each LSD.Law brief states the issue, the governing rule with citations, the court's application of that rule, and the conclusion - the same reasoning pattern you will use on exams and in practice.

Legal Issue

Did the Secretary of Health and Human Services act arbitrarily and capriciously or without substantial evidence by interpreting its regulations to deny Medicare coverage for medically necessary high-dose chemotherapy because it was administered in conjunction with a non-covered autologous stem cell transplant?

Conclusion

This case serves as a key example of the limits of agency Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Ex

Legal Rule

Under the Administrative Procedure Act, a court must set aside agency action Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non p

Legal Analysis

The court's analysis centered on the deference owed to the agency's interpretation Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Flash-to-Full Case Opinions

Flash Summary

  • A medically necessary, covered service (high-dose chemotherapy) is reimbursable even when
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint oc

Read the full analysis

The complete holding, rule, and analysis for this case are available to LSD+ subscribers.

Start 14-Day Free Trial